Clinical Trial Update: Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

View source ↗

Summary

A recruiting clinical trial investigating the role of autoantibodies against nephrin in idiopathic nephrotic syndrome, sponsored by the Mario Negri Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Nephrotic Syndrome

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Nephrotic Syndrome | Status: RECRUITING